Meta-Analysis: Short- vs. Long-term Dual Antiplatelet Therapy in Secondary Prevention for Ischemic Stroke
1 Nov, 2019 | 10:24h | UTCRelated Study: Dual Antiplatelet Therapy Should be Used for 21 Days After Minor Ischemic Stroke or High-risk Transient Ischemic Attack (link to abstract)
Related Guideline: Dual Antiplatelet Therapy for Acute High-Risk TIA and Minor Ischemic Stroke – The BMJ (free)
Related Commentary on Twitter
Short-term DAPT had better risk-benefit profile than long-term DAPT in secondary prevention of ischaemic stroke – a network meta-analysis https://t.co/suoThL5GLK@escardio #EHJQCCO @adamtimmis @cpgale3 #cardiotwitter pic.twitter.com/ppzyv37Oou
— European Society of Cardiology Journals (@ESC_Journals) October 27, 2019